The most common type of kidney cancer is called renal cell cancer (also known as RCC, renal cell carcinoma, or renal cell adenocarcinoma). It accounts for more than 9 out of 10 cases of kidney cancer.
Like all cancers, kidney cancer begins small and grows larger over time. It usually grows as a single mass or tumor within the kidney. But a kidney can have more than one tumor. Sometimes tumors are found in both kidneys at the same time. Kidney tumors are often found on CT scans or ultrasounds being done for concerns other than kidney cancer. (Source: American Cancer Society)
CyberKnife kidney cancer treatments are typically performed on an outpatient basis with one to three treatments, requiring no overnight hospital stays.
Stereotactic Body Radiosurgery Treatment (SBRT)
CyberKnife Stereotactic Body Radiation Therapy (SBRT) delivers radiation in fewer treatments than conventional radiation therapy such as 3DCRT. Tumors that lie outside of the head and neck are more likely to move due to respiratory motion and natural movements of the body. This motion makes it very difficult to precisely deliver high stereotactic doses of radiation to an intended target. CyberKnife SBRT has the unique ability to compensate for these types of movements utilizing its robotic technology and real time image guidance to effectively deliver radiosurgery treatments to very small isolated areas.